News

Gladstone in the News April 7, 2020

Tackling Heart Disease

The Stem Cell Podcast—Gladstone President Deepak Srivastava describes his work using human induced pluripotent stem cells to investigate the gene networks that dictate cell fate decisions, and how this research could lead to therapeutics for congenital heart disease and heart failure. He also describes the importance of stem cell research in fighting the COVID-19 pandemic.

Gladstone Experts COVID-19 Heart Failure Congenital Heart Disease Cardiovascular Disease Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Article February 24, 2020

Tackling Heart Disease: It Takes a Team

Gladstone researchers are collaborating to solve cardiovascular diseases using new technologies.

Gladstone Experts Research (Publication) Heart Failure Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Infectious Disease Bruneau Lab Conklin Lab Krogan Lab

Article February 24, 2020

Two Gladstone Discoveries Are STAT Madness Finalists

Why should athletes and sports fans have all the fun in March?

Gladstone Experts Institutional News Huang Lab Srivastava Lab

Gladstone in the News February 24, 2020

Here Are the Contenders for STAT Madness 2020. Voting Begins March 2.

STAT—Two Gladstone studies have been selected to participate in STAT Madness—a March Madness-style competition for scientific papers. Voting begins March 2, 2020.

Gladstone Experts Huang Lab Srivastava Lab

Video February 20, 2020

Aging: Progress with Rejuvenation and Regeneration

Aging is the single greatest risk factor for developing Alzheimer’s disease, Parkinson’s disease, and other brain diseases.

Gladstone Experts Cardiovascular Disease Neurological Disease Finkbeiner Lab McDevitt Lab Srivastava Lab Aging

Video February 17, 2020

Embracing Disruptive Technologies to Accelerate Science Overcoming Disease

From penicillin to organ transplants, so many important discoveries have dramatically changed healthcare and medicine over the past decades. But what’s really behind all this progress?

Gladstone Experts Research (Publication) Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab Yamanaka Lab

Gladstone in the News January 24, 2020

CRISPR-Cas9: The Era of Genome Editing

France 24—On France 24, Gladstone President Deepak Srivastava explains CRISPR technology and the potential is has to cure disease.

Gladstone Experts Srivastava Lab

Article January 17, 2020

Gladstone Joins a $5.7 Million Initiative Focused on Single Ventricle Heart Defects

Funds will support five top research institutions to accelerate scientific discoveries and development of treatments for single ventricle heart defects.

Grants News Release Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab Srivastava Lab

Gladstone in the News December 23, 2019

Trump Administration Ethics Board to Review Fetal Tissue Studies

Bloomberg Law—Gladstone President Deepak Srivastava comments in Bloomberg Law on the Trump Administration’s plan to implement a fetal tissue ethics review board. Srivastava states that a once-a-year review board will hold up important medical research.

Gladstone Experts Srivastava Lab

Video December 13, 2019

Evolution of Research

Gladstone started as a single institute in 1979 but has since grown to four institutes which use cutting-edge technology to tackle cardiovascular, neurological, and immunological diseases.

History Cardiovascular Disease Data Science and Biotechnology Neurological Disease Infectious Disease Greene Lab Mahley Lab Mucke Lab Pollard Lab Srivastava Lab

Article December 13, 2019

$13 Million Grant to Probe the Genome of Heart Cells

Team of six laboratories will combine expertise in heart development and -omics technology to probe genome activity and organization in heart cells.

Grants News Release Heart Failure Bruneau Lab Conklin Lab Krogan Lab Pollard Lab Srivastava Lab

Article December 12, 2019

Gladstone’s Evolution of Research

Gladstone began as a single entity with a single purpose. But as the scientists followed the science—unencumbered by the red tape of bureaucracy—the purpose, and the focus, grew.

History Institutional News Neurological Disease Cardiovascular Disease Data Science and Biotechnology Infectious Disease Finkbeiner Lab Greene Lab Mahley Lab Mucke Lab

Article December 10, 2019

Gladstone Launches Strategic Plan

Gladstone prepares for the future of discovery science with the launch of new strategic plan.

Office of the President History Institutional News Srivastava Lab

Gladstone in the News November 27, 2019

Benefits of Stem Cell Heart Therapy May Have Nothing to Do with Stem Cells, a Study on Mice Suggests

The Washington Post—Gladstone President Deepak Srivastava comments in the Washington Post on a new study that debunks controversial stem cell procedures.

Gladstone Experts Srivastava Lab

Article October 9, 2019

Connecting the Dots: From Stem Cells to Human Health

Since Shinya Yamanaka discovered a method to create human induced pluripotent stem (iPS) cells, Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.

Research (Publication) Stem Cell Core Alzheimer’s Disease Huntington’s Disease Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing